-
IMAGING COVID-19 AI
11 May, 2020
Imaging COVID-19 AI initiative is a multicenter European project to enhance computed tomography (CT) in the diagnosis of COVID-19 by using artificial intelligence. The project group will create a deep learning model for automated detection and classification of COVID-19 on CT scans, and for assessing disease severity in patients by quantification of lung involvement.
Many different hospitals and institutions across Europe will collaborate to rapidly develop an artificia... -
IMAGING COVID-19 AI
11 May, 2020
Imaging COVID-19 AI initiative is a multicenter European project to enhance computed tomography (CT) in the diagnosis of COVID-19 by using artificial intelligence. The project group will create a deep learning model for automated detection and classification of COVID-19 on CT scans, and for assessing disease severity in patients by quantification of lung involvement.
Many different hospitals and institutions across Europe will collaborate to rapidly develop an artificia... -
AMBOSS learning programs
11 May, 2020
AMBOSS is providing a number of programs for medical students, clinicians, and institutions and educators, in order to help them continue their learning as well as help them confidentially process and apply their medical knowledge at the point-of-care.
For clinicians: Find all the clinical knowledge you need to know about COVID-19 in English, Spanish, French, Italian, Portuguese, and German in our medical knowledge library.
For students: Face new challenges in the clini... -
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
11 May, 2020
Severe acute respiratory syndrome CoV-2 (SARS-CoV-2) caused the corona virus disease 2019 (COVID-19) cases in China and has become a public health emergency of international concern1. Because angiotensin-converting enzyme 2 (ACE2) is the cell entry receptor of SARS-CoV5, we used transgenic mice bearing human ACE2 and infected with SARS-CoV-2 to study the pathogenicity of the virus. Weight loss and virus replication in lung were observed in hACE2 mice infected with SARS-CoV-2. The typical ... -
What if immunity to Covid-19 doesn’t last?
11 May, 2020
Researchers say people can catch mild, cold-causing coronaviruses twice in the same year.
Starting in the fall of 2016 and continuing into 2018, researchers at Columbia University in Manhattan began collecting nasal swabs from 191 children, teachers, and emergency workers, asking them to record when they sneezed or had sore throats. The point was to create a map of common respiratory viruses and their symptoms, and how long people who recovered stayed immune to each one.Coronavirus blood-clot mystery intensifies
11 May, 2020
Purple rashes, swollen legs, clogged catheters and sudden death — blood clots, large and small, are a frequent complication of COVID-19, and researchers are just beginning to untangle why. For weeks, reports have poured in of the disease’s effects throughout the body, many of which are caused by clots. “This is like a storm of blood clots,” says Behnood Bikdeli, a fourth-year cardiology fellow at Columbia University in New York City. Anyone with a severe illness is at risk of developing c...Blood enzyme more common in men could be linked to COVID-19 Infections among males
11 May, 2020New research has suggested a key enzyme found in our blood may be the reason why men are more susceptible to COVID-19 infection.The study, published in the European Heart Journal, showed men's blood has higher levels than women's of a key enzyme used by the coronavirus to infect cells, possibly explaining why men be more likely to contract the virus.Angiotensin-converting enzyme 2 (ACE2) is found in the heart, kidneys and other organs. In COVID-19, the respiratory disease caused by the novel ...Transitioning the Hospital Out of the Pandemic: European Perspective | Solli
8 May, 2020Dr. Solli gives his lecture about transitioning the Hospital Out of the Pandemic: European Perspective.